Showing 1 - 2 results of 2 for search 'Accountancy', query time: 0.36s Refine Results
  1. 1
    Cost-effectiveness of abiraterone treatment in patients with castration-resistant prostate cancer who previously received docetaxel therapy
    by A. V. Rudakova, D. O. Meshkov, S. V. Mishugin
    Published 2014-11-01
    “..., the cost calculated with reference to one year of additional life will account for about 3.6 million rubles...”
    Get full text
    Article
  2. 2
    Cost-effectiveness of abiraterone treatment in patients with castration-resistant prostate cancer who previously received docetaxel therapy
    by A. V. Rudakova, D. O. Meshkov, S. V. Mishugin
    Published 2014-11-01
    “..., the cost calculated with reference to one year of additional life will account for about 3.6 million rubles...”
    Get full text
    Article
Search Tools: Get RSS Feed — Email this Search